Instart Logic, a cloud application delivery provider, has raised $43 million in a funding round led by new investors Four Rivers Group and Hermes Growth Partners. Previous backers Andreessen Horowitz, Kleiner Perkins Caufield and Byers, and Tenaya Capital all participated. The company will use the funds to expand globally and for research and development. “Instart Logic has a clear vision for the future of application delivery and we are uniquely positioned to reshape this market,” said Manav Mital, founder and CEO at Instart Logic. “We are building a world-class team that can develop truly innovative technology and solve customers’ toughest application delivery challenges. Companies globally are switching to Instart Logic and that is great validation and a testament to our strategy and execution.”
The Muse, a website which offers careers advice, has raised $10 million in funding from Aspect Ventures, DBL Partners and QED. The company’s seed investors include Y Combinator, 500 Startups, Tyra Banks, Great Oaks Ventures, Reddit co-founder Alexis Ohanian, Anjula Acharia-Bath, Chris Herrmannsen, former Toys R Us CEO Mike Goldstein, and the former chairman of Hearst Magazines Cathie Black. TechCrunch reports The Muse will use the funds to hire 25 employees by the end of the year.
Brazilian online education service eduK has bagged $10 million in funding from Accel Partners. The company currently boasts more than 2 million students enrolled in 600 courses, and it looking to expand into the rest of South America with the new funds, TechCrunch reports.
Autonomic Technologies, a medical device company seeking to treat severe headaches, has raised $38 million in Series D funding led by Edmond de Rothschild Investment Partners and Forbion Capital Partners. Current backers Kleiner Perkins Caufield and Byers, InterWest Partners, Novartis Venture Fund, Aberdare Ventures and the Cleveland Clinic all participated. “We are now well financed to further build out our leadership position in the growing field of neurostimulation in headache, expanding our launch to other countries in Europe and expanding the clinical evidence base of our minimally invasive treatment into other indications,” CEO Ben Pless said in a press release.